Dwight D. Kloth

1.6k total citations
22 papers, 557 citations indexed

About

Dwight D. Kloth is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dwight D. Kloth has authored 22 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dwight D. Kloth's work include Cancer Treatment and Pharmacology (5 papers), Nausea and vomiting management (4 papers) and Anesthesia and Pain Management (3 papers). Dwight D. Kloth is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Nausea and vomiting management (4 papers) and Anesthesia and Pain Management (3 papers). Dwight D. Kloth collaborates with scholars based in United States, Canada and Denmark. Dwight D. Kloth's co-authors include Robert F. Ozols, M. A. Bookman, Szymon Smoliński, Richard J. Bleicher, Peter Axelrod, Jeffrey Crawford, Saroj Vadhan‐Raj, Jamés O. Armitage, Gary H. Lyman and Douglas W. Blayney and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Dwight D. Kloth

22 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dwight D. Kloth United States	13	268	184	76	73	71	22	557
Xiaojiang Zhan China	15	105 0.4×	140 0.8×	34 0.4×	36 0.5×	64 0.9×	65	844
Jensen Pb Denmark	11	161 0.6×	97 0.5×	64 0.8×	18 0.2×	144 2.0×	35	663
Jon D. Herrington United States	16	144 0.5×	141 0.8×	61 0.8×	27 0.4×	150 2.1×	41	622
S. Bobo Tanner United States	17	118 0.4×	303 1.6×	42 0.6×	46 0.6×	92 1.3×	46	981
İdris Yücel Türkiye	13	294 1.1×	112 0.6×	22 0.3×	18 0.2×	101 1.4×	43	716
H.H.M. de Boer Netherlands	15	267 1.0×	429 2.3×	24 0.3×	30 0.4×	148 2.1×	34	740
Roumen Nakov Germany	13	193 0.7×	274 1.5×	15 0.2×	38 0.5×	93 1.3×	26	864
Efstathios Tapazoglou United States	17	310 1.2×	518 2.8×	23 0.3×	35 0.5×	261 3.7×	26	1.1k
James A. Edney United States	17	194 0.7×	293 1.6×	24 0.3×	28 0.4×	226 3.2×	28	877
Jianhong Zhu China	10	136 0.5×	85 0.5×	24 0.3×	60 0.8×	174 2.5×	43	546

Countries citing papers authored by Dwight D. Kloth

Since Specialization

Citations

This map shows the geographic impact of Dwight D. Kloth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwight D. Kloth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwight D. Kloth more than expected).

Fields of papers citing papers by Dwight D. Kloth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwight D. Kloth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwight D. Kloth. The network helps show where Dwight D. Kloth may publish in the future.

Co-authorship network of co-authors of Dwight D. Kloth

This figure shows the co-authorship network connecting the top 25 collaborators of Dwight D. Kloth. A scholar is included among the top collaborators of Dwight D. Kloth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwight D. Kloth. Dwight D. Kloth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwartzberg, Lee S., Rudolph M. Navari, Kathryn J. Ruddy, et al.. (2023). Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. Supportive Care in Cancer. 31(11). 654–654. 1 indexed citations

Navari, Rudolph M., G. Binder, Alex Molassiotis, et al.. (2022). Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles. The Oncologist. 28(3). 208–213. 7 indexed citations

Navari, Rudolph M., G. Binder, Alex Molassiotis, et al.. (2021). Abstract PS13-09: Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average. Cancer Research. 81(4_Supplement). PS13–9. 1 indexed citations

Jain, Angela, et al.. (2017). Inpatient 100% mortality review at a NCI Comprehensive Cancer Center Hospital.. Journal of Clinical Oncology. 35(8_suppl). 88–88. 2 indexed citations

Dotan, Efrat, Karthik Devarajan, Andrew H. Beck, et al.. (2014). Patterns of Use and Tolerance of Anti–Epidermal Growth Factor Receptor Antibodies in Older Adults With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 13(3). 192–198. 5 indexed citations

Dotan, Efrat, et al.. (2012). Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 30(4_suppl). 657–657. 1 indexed citations

Crawford, Jeffrey, Jeffrey W. Allen, Jamés O. Armitage, et al.. (2011). Myeloid Growth Factors. Journal of the National Comprehensive Cancer Network. 9(8). 914–932. 112 indexed citations

Kloth, Dwight D., et al.. (2010). The escalating role of epidermal growth factor receptor inhibitors in cancer management: clinical considerations for the health system pharmacist.. PubMed. 35(4). 219–29. 4 indexed citations

Bleicher, Richard J., et al.. (2009). Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. Journal of Surgical Oncology. 99(6). 356–360. 37 indexed citations

10.

Ettinger, David S., Sally Barbour, Michael Berger, et al.. (2009). Antiemesis. Journal of the National Comprehensive Cancer Network. 7(5). 572–595. 83 indexed citations

11.

Arbuckle, Rebecca, Niesha Griffith, Philip E. Johnson, et al.. (2008). Continued Challenges with the Use of Erythropoiesis‐Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy‐Guided Health Care. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(5P2). 9 indexed citations

12.

Kloth, Dwight D.. (2008). New pharmacologic findings for the treatment of PONV and PDNV. American Journal of Health-System Pharmacy. 66(1_Supplement_1). S11–S18. 16 indexed citations

13.

Crawford, Jeffrey, Betsy Althaus, Jamés O. Armitage, et al.. (2005). Myeloid Growth Factors Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 3(4). 540–540. 18 indexed citations

14.

Kloth, Dwight D.. (2002). Prevention of Chemotherapy Medication Errors. Journal of Pharmacy Practice. 15(1). 17–31. 14 indexed citations

15.

Bookman, M. A., et al.. (1997). Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions. Annals of Oncology. 8(6). 611–614. 92 indexed citations

16.

Kloth, Dwight D., et al.. (1997). Receiver operating characteristic (ROC) curve analysis of transrectal ultrasonographic prostate cancer detection.. PubMed. 4(1). 293–299. 1 indexed citations

17.

Bookman, M. A., et al.. (1997). Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.. PubMed. 24(6 Suppl 19). S19–13. 28 indexed citations

18.

Moussa, Madeleine, et al.. (1997). Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.. PubMed. 20(6). 371–80. 37 indexed citations

19.

Kloth, Dwight D., et al.. (1996). Acute Encephalopathy Attributed to 5‐FU. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(2). 311–313. 15 indexed citations

20.

Tegtmeier, Bernard, et al.. (1990). A prospective, randomized double-blind study of the use of antibiotics at the time of mastectomy.. PubMed. 170(1). 12–6. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact